nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—CYP3A4—Thiotepa—sarcoma	0.14	0.202	CbGbCtD
Prednisolone—ABCB1—Dactinomycin—sarcoma	0.112	0.162	CbGbCtD
Prednisolone—ABCB1—Mitoxantrone—sarcoma	0.1	0.145	CbGbCtD
Prednisolone—ABCB1—Vincristine—sarcoma	0.0689	0.0996	CbGbCtD
Prednisolone—ABCB1—Etoposide—sarcoma	0.0632	0.0913	CbGbCtD
Prednisolone—CYP3A4—Mitoxantrone—sarcoma	0.06	0.0868	CbGbCtD
Prednisolone—ABCB1—Doxorubicin—sarcoma	0.0431	0.0623	CbGbCtD
Prednisolone—CYP3A4—Vincristine—sarcoma	0.0413	0.0597	CbGbCtD
Prednisolone—CYP3A4—Etoposide—sarcoma	0.0378	0.0547	CbGbCtD
Prednisolone—CYP3A4—Doxorubicin—sarcoma	0.0258	0.0373	CbGbCtD
Prednisolone—Leukoderma—Doxorubicin—sarcoma	0.00245	0.00911	CcSEcCtD
Prednisolone—Neuropathy—Vincristine—sarcoma	0.00233	0.00865	CcSEcCtD
Prednisolone—Embolism venous—Epirubicin—sarcoma	0.00223	0.00829	CcSEcCtD
Prednisolone—Ecchymosis—Mitoxantrone—sarcoma	0.00218	0.00812	CcSEcCtD
Prednisolone—Hypernatraemia—Epirubicin—sarcoma	0.00214	0.00796	CcSEcCtD
Prednisolone—Embolism venous—Doxorubicin—sarcoma	0.00206	0.00767	CcSEcCtD
Prednisolone—SERPINA6—hematopoietic system—sarcoma	0.00201	0.0508	CbGeAlD
Prednisolone—Hypernatraemia—Doxorubicin—sarcoma	0.00198	0.00737	CcSEcCtD
Prednisolone—Cardiac failure congestive—Mitoxantrone—sarcoma	0.00193	0.00718	CcSEcCtD
Prednisolone—Cardiac arrest—Thiotepa—sarcoma	0.00193	0.00717	CcSEcCtD
Prednisolone—NR3C2—myometrium—sarcoma	0.00191	0.0483	CbGeAlD
Prednisolone—Neuropathy—Etoposide—sarcoma	0.00188	0.00701	CcSEcCtD
Prednisolone—CYP2A6—seminal vesicle—sarcoma	0.00184	0.0465	CbGeAlD
Prednisolone—Optic neuritis—Epirubicin—sarcoma	0.00183	0.0068	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00181	0.00673	CcSEcCtD
Prednisolone—Embolism—Epirubicin—sarcoma	0.00175	0.00652	CcSEcCtD
Prednisolone—Keratitis—Epirubicin—sarcoma	0.00173	0.00645	CcSEcCtD
Prednisolone—NR3C2—seminal vesicle—sarcoma	0.00173	0.0436	CbGeAlD
Prednisolone—Cardiac arrest—Vincristine—sarcoma	0.00171	0.00636	CcSEcCtD
Prednisolone—Optic neuritis—Doxorubicin—sarcoma	0.00169	0.0063	CcSEcCtD
Prednisolone—NR3C2—hematopoietic system—sarcoma	0.00164	0.0414	CbGeAlD
Prednisolone—Embolism—Doxorubicin—sarcoma	0.00162	0.00603	CcSEcCtD
Prednisolone—Cardiac failure congestive—Etoposide—sarcoma	0.00161	0.00598	CcSEcCtD
Prednisolone—Keratitis—Doxorubicin—sarcoma	0.0016	0.00597	CcSEcCtD
Prednisolone—Weight increased—Thiotepa—sarcoma	0.0016	0.00593	CcSEcCtD
Prednisolone—Hepatomegaly—Epirubicin—sarcoma	0.00159	0.00591	CcSEcCtD
Prednisolone—Muscular weakness—Vincristine—sarcoma	0.00159	0.0059	CcSEcCtD
Prednisolone—NR3C2—connective tissue—sarcoma	0.00158	0.0399	CbGeAlD
Prednisolone—Blister—Epirubicin—sarcoma	0.00156	0.00581	CcSEcCtD
Prednisolone—Dermatitis atopic—Epirubicin—sarcoma	0.00152	0.00565	CcSEcCtD
Prednisolone—Conjunctivitis—Thiotepa—sarcoma	0.00152	0.00565	CcSEcCtD
Prednisolone—Neuritis—Epirubicin—sarcoma	0.00151	0.00561	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Etoposide—sarcoma	0.00151	0.0056	CcSEcCtD
Prednisolone—Sweating increased—Mitoxantrone—sarcoma	0.00147	0.00549	CcSEcCtD
Prednisolone—Hepatomegaly—Doxorubicin—sarcoma	0.00147	0.00547	CcSEcCtD
Prednisolone—NR3C2—smooth muscle tissue—sarcoma	0.00145	0.0365	CbGeAlD
Prednisolone—Blister—Doxorubicin—sarcoma	0.00144	0.00537	CcSEcCtD
Prednisolone—Abscess—Epirubicin—sarcoma	0.00142	0.00529	CcSEcCtD
Prednisolone—Haemoglobin—Thiotepa—sarcoma	0.00141	0.00525	CcSEcCtD
Prednisolone—SLCO1A2—hematopoietic system—sarcoma	0.00141	0.0355	CbGeAlD
Prednisolone—Dermatitis atopic—Doxorubicin—sarcoma	0.00141	0.00523	CcSEcCtD
Prednisolone—Haemorrhage—Thiotepa—sarcoma	0.0014	0.00522	CcSEcCtD
Prednisolone—Neuritis—Doxorubicin—sarcoma	0.00139	0.00519	CcSEcCtD
Prednisolone—Stinging—Epirubicin—sarcoma	0.00139	0.00517	CcSEcCtD
Prednisolone—Cardiac arrest—Etoposide—sarcoma	0.00139	0.00515	CcSEcCtD
Prednisolone—Weight increased—Mitoxantrone—sarcoma	0.00138	0.00513	CcSEcCtD
Prednisolone—Petechiae—Epirubicin—sarcoma	0.00137	0.00509	CcSEcCtD
Prednisolone—Acute coronary syndrome—Vincristine—sarcoma	0.00137	0.00508	CcSEcCtD
Prednisolone—Myocardial infarction—Vincristine—sarcoma	0.00136	0.00505	CcSEcCtD
Prednisolone—Neuropathy peripheral—Vincristine—sarcoma	0.00136	0.00505	CcSEcCtD
Prednisolone—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00133	0.00495	CcSEcCtD
Prednisolone—Myocardial infarction—Mitoxantrone—sarcoma	0.00132	0.00492	CcSEcCtD
Prednisolone—Abscess—Doxorubicin—sarcoma	0.00132	0.00489	CcSEcCtD
Prednisolone—Conjunctivitis—Mitoxantrone—sarcoma	0.00131	0.00488	CcSEcCtD
Prednisolone—SERPINA6—bone marrow—sarcoma	0.00129	0.0325	CbGeAlD
Prednisolone—Stinging—Doxorubicin—sarcoma	0.00128	0.00478	CcSEcCtD
Prednisolone—Petechiae—Doxorubicin—sarcoma	0.00127	0.00471	CcSEcCtD
Prednisolone—Arrhythmia—Thiotepa—sarcoma	0.00125	0.00466	CcSEcCtD
Prednisolone—NR3C2—cardiac atrium—sarcoma	0.00125	0.0315	CbGeAlD
Prednisolone—Viral infection—Epirubicin—sarcoma	0.00125	0.00463	CcSEcCtD
Prednisolone—NR3C2—uterus—sarcoma	0.00124	0.0313	CbGeAlD
Prednisolone—Arthropathy—Epirubicin—sarcoma	0.00124	0.0046	CcSEcCtD
Prednisolone—Bradycardia—Mitoxantrone—sarcoma	0.00123	0.00459	CcSEcCtD
Prednisolone—Sweating increased—Etoposide—sarcoma	0.00123	0.00456	CcSEcCtD
Prednisolone—Erythema—Thiotepa—sarcoma	0.00122	0.00454	CcSEcCtD
Prednisolone—Herpes simplex—Epirubicin—sarcoma	0.00122	0.00454	CcSEcCtD
Prednisolone—Haemoglobin—Mitoxantrone—sarcoma	0.00122	0.00453	CcSEcCtD
Prednisolone—Erythema—Dactinomycin—sarcoma	0.00121	0.00451	CcSEcCtD
Prednisolone—Haemorrhage—Mitoxantrone—sarcoma	0.00121	0.00451	CcSEcCtD
Prednisolone—Viral infection—Doxorubicin—sarcoma	0.00115	0.00429	CcSEcCtD
Prednisolone—Vision blurred—Thiotepa—sarcoma	0.00115	0.00428	CcSEcCtD
Prednisolone—Arthropathy—Doxorubicin—sarcoma	0.00114	0.00426	CcSEcCtD
Prednisolone—Herpes simplex—Doxorubicin—sarcoma	0.00113	0.0042	CcSEcCtD
Prednisolone—Hiccups—Epirubicin—sarcoma	0.00112	0.00419	CcSEcCtD
Prednisolone—Ill-defined disorder—Dactinomycin—sarcoma	0.00112	0.00418	CcSEcCtD
Prednisolone—Acute coronary syndrome—Etoposide—sarcoma	0.00111	0.00412	CcSEcCtD
Prednisolone—Myocardial infarction—Etoposide—sarcoma	0.0011	0.00409	CcSEcCtD
Prednisolone—Neuropathy peripheral—Etoposide—sarcoma	0.0011	0.00409	CcSEcCtD
Prednisolone—Malaise—Dactinomycin—sarcoma	0.00109	0.00407	CcSEcCtD
Prednisolone—NR3C2—tendon—sarcoma	0.00109	0.0274	CbGeAlD
Prednisolone—Arrhythmia—Mitoxantrone—sarcoma	0.00108	0.00403	CcSEcCtD
Prednisolone—Fluid retention—Epirubicin—sarcoma	0.00107	0.00397	CcSEcCtD
Prednisolone—Convulsion—Thiotepa—sarcoma	0.00106	0.00394	CcSEcCtD
Prednisolone—Neuropathy—Epirubicin—sarcoma	0.00106	0.00393	CcSEcCtD
Prednisolone—Erythema—Mitoxantrone—sarcoma	0.00105	0.00392	CcSEcCtD
Prednisolone—Hypertension—Thiotepa—sarcoma	0.00105	0.00392	CcSEcCtD
Prednisolone—SERPINA6—liver—sarcoma	0.00104	0.0263	CbGeAlD
Prednisolone—Hiccups—Doxorubicin—sarcoma	0.00104	0.00387	CcSEcCtD
Prednisolone—NR3C1—myometrium—sarcoma	0.00103	0.0259	CbGeAlD
Prednisolone—Discomfort—Dactinomycin—sarcoma	0.00102	0.00379	CcSEcCtD
Prednisolone—Ecchymosis—Epirubicin—sarcoma	0.00102	0.00378	CcSEcCtD
Prednisolone—Pulmonary oedema—Epirubicin—sarcoma	0.001	0.00373	CcSEcCtD
Prednisolone—Vision blurred—Mitoxantrone—sarcoma	0.000994	0.0037	CcSEcCtD
Prednisolone—Oedema—Dactinomycin—sarcoma	0.000989	0.00368	CcSEcCtD
Prednisolone—Fluid retention—Doxorubicin—sarcoma	0.000988	0.00368	CcSEcCtD
Prednisolone—NR3C1—embryo—sarcoma	0.000987	0.0249	CbGeAlD
Prednisolone—Ill-defined disorder—Mitoxantrone—sarcoma	0.000979	0.00364	CcSEcCtD
Prednisolone—Neuropathy—Doxorubicin—sarcoma	0.000977	0.00364	CcSEcCtD
Prednisolone—Vertigo—Vincristine—sarcoma	0.000973	0.00362	CcSEcCtD
Prednisolone—Tachycardia—Thiotepa—sarcoma	0.000973	0.00362	CcSEcCtD
Prednisolone—Malaise—Mitoxantrone—sarcoma	0.000951	0.00354	CcSEcCtD
Prednisolone—Thrombophlebitis—Epirubicin—sarcoma	0.000943	0.00351	CcSEcCtD
Prednisolone—Ecchymosis—Doxorubicin—sarcoma	0.000941	0.0035	CcSEcCtD
Prednisolone—Diabetes mellitus—Epirubicin—sarcoma	0.000939	0.00349	CcSEcCtD
Prednisolone—Convulsion—Vincristine—sarcoma	0.000938	0.00349	CcSEcCtD
Prednisolone—Hypertension—Vincristine—sarcoma	0.000935	0.00348	CcSEcCtD
Prednisolone—NR3C1—seminal vesicle—sarcoma	0.000927	0.0234	CbGeAlD
Prednisolone—Pulmonary oedema—Doxorubicin—sarcoma	0.000926	0.00345	CcSEcCtD
Prednisolone—Convulsion—Mitoxantrone—sarcoma	0.000914	0.0034	CcSEcCtD
Prednisolone—Hypertension—Mitoxantrone—sarcoma	0.000911	0.00339	CcSEcCtD
Prednisolone—CYP2A6—liver—sarcoma	0.000908	0.0229	CbGeAlD
Prednisolone—Cardiac failure congestive—Epirubicin—sarcoma	0.0009	0.00335	CcSEcCtD
Prednisolone—NR3C2—testis—sarcoma	0.0009	0.0227	CbGeAlD
Prednisolone—Paraesthesia—Thiotepa—sarcoma	0.000895	0.00333	CcSEcCtD
Prednisolone—Discomfort—Mitoxantrone—sarcoma	0.000887	0.0033	CcSEcCtD
Prednisolone—Anaphylactic shock—Vincristine—sarcoma	0.000884	0.00329	CcSEcCtD
Prednisolone—Oedema—Vincristine—sarcoma	0.000884	0.00329	CcSEcCtD
Prednisolone—NR3C1—hematopoietic system—sarcoma	0.000881	0.0222	CbGeAlD
Prednisolone—Thrombophlebitis—Doxorubicin—sarcoma	0.000873	0.00325	CcSEcCtD
Prednisolone—Increased appetite—Epirubicin—sarcoma	0.000869	0.00323	CcSEcCtD
Prednisolone—Diabetes mellitus—Doxorubicin—sarcoma	0.000869	0.00323	CcSEcCtD
Prednisolone—Oedema—Mitoxantrone—sarcoma	0.000861	0.0032	CcSEcCtD
Prednisolone—Anaphylactic shock—Mitoxantrone—sarcoma	0.000861	0.0032	CcSEcCtD
Prednisolone—Hyperhidrosis—Vincristine—sarcoma	0.000854	0.00318	CcSEcCtD
Prednisolone—Dermatitis bullous—Epirubicin—sarcoma	0.000854	0.00318	CcSEcCtD
Prednisolone—Pain—Thiotepa—sarcoma	0.000852	0.00317	CcSEcCtD
Prednisolone—NR3C2—liver—sarcoma	0.000851	0.0215	CbGeAlD
Prednisolone—NR3C1—connective tissue—sarcoma	0.000848	0.0214	CbGeAlD
Prednisolone—Shock—Mitoxantrone—sarcoma	0.000847	0.00315	CcSEcCtD
Prednisolone—Pain—Dactinomycin—sarcoma	0.000846	0.00315	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Epirubicin—sarcoma	0.000844	0.00314	CcSEcCtD
Prednisolone—Tachycardia—Mitoxantrone—sarcoma	0.00084	0.00313	CcSEcCtD
Prednisolone—Cardiac failure congestive—Doxorubicin—sarcoma	0.000833	0.0031	CcSEcCtD
Prednisolone—Hyperhidrosis—Mitoxantrone—sarcoma	0.000832	0.0031	CcSEcCtD
Prednisolone—Feeling abnormal—Thiotepa—sarcoma	0.000821	0.00306	CcSEcCtD
Prednisolone—Osteoarthritis—Epirubicin—sarcoma	0.000817	0.00304	CcSEcCtD
Prednisolone—Feeling abnormal—Dactinomycin—sarcoma	0.000815	0.00303	CcSEcCtD
Prednisolone—Ill-defined disorder—Etoposide—sarcoma	0.000814	0.00303	CcSEcCtD
Prednisolone—Increased appetite—Doxorubicin—sarcoma	0.000804	0.00299	CcSEcCtD
Prednisolone—Affect lability—Epirubicin—sarcoma	0.000804	0.00299	CcSEcCtD
Prednisolone—Insomnia—Vincristine—sarcoma	0.000799	0.00297	CcSEcCtD
Prednisolone—Paraesthesia—Vincristine—sarcoma	0.000794	0.00295	CcSEcCtD
Prednisolone—Urticaria—Thiotepa—sarcoma	0.000792	0.00295	CcSEcCtD
Prednisolone—Malaise—Etoposide—sarcoma	0.000791	0.00294	CcSEcCtD
Prednisolone—Dermatitis bullous—Doxorubicin—sarcoma	0.000791	0.00294	CcSEcCtD
Prednisolone—Vertigo—Etoposide—sarcoma	0.000788	0.00293	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000781	0.0029	CcSEcCtD
Prednisolone—Cardiac arrest—Epirubicin—sarcoma	0.000776	0.00289	CcSEcCtD
Prednisolone—NR3C1—smooth muscle tissue—sarcoma	0.000776	0.0196	CbGeAlD
Prednisolone—Mood swings—Epirubicin—sarcoma	0.000774	0.00288	CcSEcCtD
Prednisolone—Paraesthesia—Mitoxantrone—sarcoma	0.000773	0.00288	CcSEcCtD
Prednisolone—SLCO1A2—testis—sarcoma	0.000771	0.0195	CbGeAlD
Prednisolone—Loss of consciousness—Etoposide—sarcoma	0.000771	0.00287	CcSEcCtD
Prednisolone—NR3C1—skin of body—sarcoma	0.000766	0.0193	CbGeAlD
Prednisolone—Convulsion—Etoposide—sarcoma	0.00076	0.00283	CcSEcCtD
Prednisolone—Hypertension—Etoposide—sarcoma	0.000757	0.00282	CcSEcCtD
Prednisolone—Pain—Vincristine—sarcoma	0.000756	0.00281	CcSEcCtD
Prednisolone—Osteoarthritis—Doxorubicin—sarcoma	0.000756	0.00281	CcSEcCtD
Prednisolone—Dry skin—Epirubicin—sarcoma	0.000748	0.00278	CcSEcCtD
Prednisolone—Affect lability—Doxorubicin—sarcoma	0.000744	0.00277	CcSEcCtD
Prednisolone—Discomfort—Etoposide—sarcoma	0.000738	0.00275	CcSEcCtD
Prednisolone—Pain—Mitoxantrone—sarcoma	0.000736	0.00274	CcSEcCtD
Prednisolone—Hypersensitivity—Thiotepa—sarcoma	0.000734	0.00273	CcSEcCtD
Prednisolone—SLCO1A2—liver—sarcoma	0.000729	0.0184	CbGeAlD
Prednisolone—Hypersensitivity—Dactinomycin—sarcoma	0.000729	0.00271	CcSEcCtD
Prednisolone—Muscular weakness—Epirubicin—sarcoma	0.00072	0.00268	CcSEcCtD
Prednisolone—Cardiac arrest—Doxorubicin—sarcoma	0.000718	0.00267	CcSEcCtD
Prednisolone—Anaphylactic shock—Etoposide—sarcoma	0.000716	0.00266	CcSEcCtD
Prednisolone—Mood swings—Doxorubicin—sarcoma	0.000716	0.00266	CcSEcCtD
Prednisolone—Abdominal distension—Epirubicin—sarcoma	0.00071	0.00264	CcSEcCtD
Prednisolone—Feeling abnormal—Mitoxantrone—sarcoma	0.000709	0.00264	CcSEcCtD
Prednisolone—Tachycardia—Etoposide—sarcoma	0.000699	0.0026	CcSEcCtD
Prednisolone—Dry skin—Doxorubicin—sarcoma	0.000693	0.00258	CcSEcCtD
Prednisolone—Hyperhidrosis—Etoposide—sarcoma	0.000692	0.00258	CcSEcCtD
Prednisolone—Pancreatitis—Epirubicin—sarcoma	0.000692	0.00257	CcSEcCtD
Prednisolone—Urticaria—Mitoxantrone—sarcoma	0.000684	0.00254	CcSEcCtD
Prednisolone—NR3C1—cardiac atrium—sarcoma	0.000669	0.0169	CbGeAlD
Prednisolone—Muscular weakness—Doxorubicin—sarcoma	0.000666	0.00248	CcSEcCtD
Prednisolone—CYP3A4—hematopoietic system—sarcoma	0.000666	0.0168	CbGeAlD
Prednisolone—NR3C1—uterus—sarcoma	0.000665	0.0168	CbGeAlD
Prednisolone—Dizziness—Thiotepa—sarcoma	0.000659	0.00245	CcSEcCtD
Prednisolone—Abdominal distension—Doxorubicin—sarcoma	0.000657	0.00245	CcSEcCtD
Prednisolone—NR3C2—lymph node—sarcoma	0.000652	0.0165	CbGeAlD
Prednisolone—Hypersensitivity—Vincristine—sarcoma	0.000651	0.00242	CcSEcCtD
Prednisolone—Paraesthesia—Etoposide—sarcoma	0.000643	0.00239	CcSEcCtD
Prednisolone—Weight increased—Epirubicin—sarcoma	0.000642	0.00239	CcSEcCtD
Prednisolone—Pancreatitis—Doxorubicin—sarcoma	0.00064	0.00238	CcSEcCtD
Prednisolone—Hypersensitivity—Mitoxantrone—sarcoma	0.000634	0.00236	CcSEcCtD
Prednisolone—Rash—Thiotepa—sarcoma	0.000628	0.00234	CcSEcCtD
Prednisolone—Dermatitis—Thiotepa—sarcoma	0.000628	0.00234	CcSEcCtD
Prednisolone—Headache—Thiotepa—sarcoma	0.000624	0.00232	CcSEcCtD
Prednisolone—Rash—Dactinomycin—sarcoma	0.000624	0.00232	CcSEcCtD
Prednisolone—NR3C1—lymphoid tissue—sarcoma	0.00062	0.0156	CbGeAlD
Prednisolone—Neuropathy peripheral—Epirubicin—sarcoma	0.000617	0.00229	CcSEcCtD
Prednisolone—Pain—Etoposide—sarcoma	0.000612	0.00228	CcSEcCtD
Prednisolone—Conjunctivitis—Epirubicin—sarcoma	0.000612	0.00228	CcSEcCtD
Prednisolone—Weight increased—Doxorubicin—sarcoma	0.000594	0.00221	CcSEcCtD
Prednisolone—Nausea—Thiotepa—sarcoma	0.000592	0.0022	CcSEcCtD
Prednisolone—Feeling abnormal—Etoposide—sarcoma	0.00059	0.0022	CcSEcCtD
Prednisolone—Nausea—Dactinomycin—sarcoma	0.000588	0.00219	CcSEcCtD
Prednisolone—Dizziness—Vincristine—sarcoma	0.000584	0.00217	CcSEcCtD
Prednisolone—NR3C1—tendon—sarcoma	0.000583	0.0147	CbGeAlD
Prednisolone—Bradycardia—Epirubicin—sarcoma	0.000575	0.00214	CcSEcCtD
Prednisolone—Neuropathy peripheral—Doxorubicin—sarcoma	0.000571	0.00212	CcSEcCtD
Prednisolone—Urticaria—Etoposide—sarcoma	0.000569	0.00212	CcSEcCtD
Prednisolone—Haemoglobin—Epirubicin—sarcoma	0.000568	0.00211	CcSEcCtD
Prednisolone—Conjunctivitis—Doxorubicin—sarcoma	0.000566	0.00211	CcSEcCtD
Prednisolone—Haemorrhage—Epirubicin—sarcoma	0.000565	0.0021	CcSEcCtD
Prednisolone—NR3C1—bone marrow—sarcoma	0.000565	0.0142	CbGeAlD
Prednisolone—Rash—Vincristine—sarcoma	0.000557	0.00207	CcSEcCtD
Prednisolone—Dermatitis—Vincristine—sarcoma	0.000557	0.00207	CcSEcCtD
Prednisolone—Headache—Vincristine—sarcoma	0.000554	0.00206	CcSEcCtD
Prednisolone—ABCB1—myometrium—sarcoma	0.000549	0.0139	CbGeAlD
Prednisolone—Visual impairment—Epirubicin—sarcoma	0.000544	0.00203	CcSEcCtD
Prednisolone—Rash—Mitoxantrone—sarcoma	0.000543	0.00202	CcSEcCtD
Prednisolone—Dermatitis—Mitoxantrone—sarcoma	0.000542	0.00202	CcSEcCtD
Prednisolone—Headache—Mitoxantrone—sarcoma	0.000539	0.00201	CcSEcCtD
Prednisolone—Bradycardia—Doxorubicin—sarcoma	0.000532	0.00198	CcSEcCtD
Prednisolone—ABCB1—embryo—sarcoma	0.000528	0.0133	CbGeAlD
Prednisolone—Hypersensitivity—Etoposide—sarcoma	0.000528	0.00196	CcSEcCtD
Prednisolone—Haemoglobin—Doxorubicin—sarcoma	0.000525	0.00195	CcSEcCtD
Prednisolone—Nausea—Vincristine—sarcoma	0.000525	0.00195	CcSEcCtD
Prednisolone—Haemorrhage—Doxorubicin—sarcoma	0.000523	0.00194	CcSEcCtD
Prednisolone—Nausea—Mitoxantrone—sarcoma	0.000511	0.0019	CcSEcCtD
Prednisolone—Arrhythmia—Epirubicin—sarcoma	0.000505	0.00188	CcSEcCtD
Prednisolone—Visual impairment—Doxorubicin—sarcoma	0.000504	0.00187	CcSEcCtD
Prednisolone—ABCB1—seminal vesicle—sarcoma	0.000496	0.0125	CbGeAlD
Prednisolone—Erythema—Epirubicin—sarcoma	0.000492	0.00183	CcSEcCtD
Prednisolone—NR3C1—testis—sarcoma	0.000483	0.0122	CbGeAlD
Prednisolone—Dizziness—Etoposide—sarcoma	0.000473	0.00176	CcSEcCtD
Prednisolone—ABCB1—hematopoietic system—sarcoma	0.000471	0.0119	CbGeAlD
Prednisolone—Arrhythmia—Doxorubicin—sarcoma	0.000467	0.00174	CcSEcCtD
Prednisolone—Vision blurred—Epirubicin—sarcoma	0.000463	0.00172	CcSEcCtD
Prednisolone—Ill-defined disorder—Epirubicin—sarcoma	0.000456	0.0017	CcSEcCtD
Prednisolone—NR3C1—liver—sarcoma	0.000456	0.0115	CbGeAlD
Prednisolone—Erythema—Doxorubicin—sarcoma	0.000455	0.00169	CcSEcCtD
Prednisolone—Rash—Etoposide—sarcoma	0.000451	0.00168	CcSEcCtD
Prednisolone—Dermatitis—Etoposide—sarcoma	0.000451	0.00168	CcSEcCtD
Prednisolone—Headache—Etoposide—sarcoma	0.000449	0.00167	CcSEcCtD
Prednisolone—Malaise—Epirubicin—sarcoma	0.000443	0.00165	CcSEcCtD
Prednisolone—Vertigo—Epirubicin—sarcoma	0.000442	0.00164	CcSEcCtD
Prednisolone—Syncope—Epirubicin—sarcoma	0.000441	0.00164	CcSEcCtD
Prednisolone—Loss of consciousness—Epirubicin—sarcoma	0.000432	0.00161	CcSEcCtD
Prednisolone—Vision blurred—Doxorubicin—sarcoma	0.000429	0.0016	CcSEcCtD
Prednisolone—Convulsion—Epirubicin—sarcoma	0.000426	0.00159	CcSEcCtD
Prednisolone—Nausea—Etoposide—sarcoma	0.000425	0.00158	CcSEcCtD
Prednisolone—Hypertension—Epirubicin—sarcoma	0.000425	0.00158	CcSEcCtD
Prednisolone—Ill-defined disorder—Doxorubicin—sarcoma	0.000422	0.00157	CcSEcCtD
Prednisolone—Discomfort—Epirubicin—sarcoma	0.000414	0.00154	CcSEcCtD
Prednisolone—Malaise—Doxorubicin—sarcoma	0.00041	0.00153	CcSEcCtD
Prednisolone—Vertigo—Doxorubicin—sarcoma	0.000409	0.00152	CcSEcCtD
Prednisolone—Syncope—Doxorubicin—sarcoma	0.000408	0.00152	CcSEcCtD
Prednisolone—Oedema—Epirubicin—sarcoma	0.000401	0.00149	CcSEcCtD
Prednisolone—Anaphylactic shock—Epirubicin—sarcoma	0.000401	0.00149	CcSEcCtD
Prednisolone—Loss of consciousness—Doxorubicin—sarcoma	0.0004	0.00149	CcSEcCtD
Prednisolone—Shock—Epirubicin—sarcoma	0.000395	0.00147	CcSEcCtD
Prednisolone—Convulsion—Doxorubicin—sarcoma	0.000394	0.00147	CcSEcCtD
Prednisolone—Hypertension—Doxorubicin—sarcoma	0.000393	0.00146	CcSEcCtD
Prednisolone—Tachycardia—Epirubicin—sarcoma	0.000392	0.00146	CcSEcCtD
Prednisolone—Hyperhidrosis—Epirubicin—sarcoma	0.000388	0.00144	CcSEcCtD
Prednisolone—Discomfort—Doxorubicin—sarcoma	0.000383	0.00142	CcSEcCtD
Prednisolone—Oedema—Doxorubicin—sarcoma	0.000371	0.00138	CcSEcCtD
Prednisolone—Anaphylactic shock—Doxorubicin—sarcoma	0.000371	0.00138	CcSEcCtD
Prednisolone—Shock—Doxorubicin—sarcoma	0.000365	0.00136	CcSEcCtD
Prednisolone—Insomnia—Epirubicin—sarcoma	0.000363	0.00135	CcSEcCtD
Prednisolone—Tachycardia—Doxorubicin—sarcoma	0.000362	0.00135	CcSEcCtD
Prednisolone—Paraesthesia—Epirubicin—sarcoma	0.00036	0.00134	CcSEcCtD
Prednisolone—Hyperhidrosis—Doxorubicin—sarcoma	0.000359	0.00134	CcSEcCtD
Prednisolone—ABCB1—uterus—sarcoma	0.000356	0.00899	CbGeAlD
Prednisolone—NR3C1—lymph node—sarcoma	0.00035	0.00883	CbGeAlD
Prednisolone—CYP3A4—liver—sarcoma	0.000345	0.00871	CbGeAlD
Prednisolone—Pain—Epirubicin—sarcoma	0.000343	0.00128	CcSEcCtD
Prednisolone—Insomnia—Doxorubicin—sarcoma	0.000336	0.00125	CcSEcCtD
Prednisolone—Paraesthesia—Doxorubicin—sarcoma	0.000333	0.00124	CcSEcCtD
Prednisolone—ABCB1—lymphoid tissue—sarcoma	0.000332	0.00838	CbGeAlD
Prednisolone—Feeling abnormal—Epirubicin—sarcoma	0.000331	0.00123	CcSEcCtD
Prednisolone—Urticaria—Epirubicin—sarcoma	0.000319	0.00119	CcSEcCtD
Prednisolone—Pain—Doxorubicin—sarcoma	0.000318	0.00118	CcSEcCtD
Prednisolone—Feeling abnormal—Doxorubicin—sarcoma	0.000306	0.00114	CcSEcCtD
Prednisolone—ABCB1—bone marrow—sarcoma	0.000302	0.00763	CbGeAlD
Prednisolone—Hypersensitivity—Epirubicin—sarcoma	0.000296	0.0011	CcSEcCtD
Prednisolone—Urticaria—Doxorubicin—sarcoma	0.000295	0.0011	CcSEcCtD
Prednisolone—Hypersensitivity—Doxorubicin—sarcoma	0.000274	0.00102	CcSEcCtD
Prednisolone—Dizziness—Epirubicin—sarcoma	0.000265	0.000987	CcSEcCtD
Prednisolone—ABCB1—testis—sarcoma	0.000258	0.00652	CbGeAlD
Prednisolone—Rash—Epirubicin—sarcoma	0.000253	0.000941	CcSEcCtD
Prednisolone—Dermatitis—Epirubicin—sarcoma	0.000253	0.000941	CcSEcCtD
Prednisolone—Headache—Epirubicin—sarcoma	0.000251	0.000935	CcSEcCtD
Prednisolone—Dizziness—Doxorubicin—sarcoma	0.000246	0.000914	CcSEcCtD
Prednisolone—ABCB1—liver—sarcoma	0.000244	0.00617	CbGeAlD
Prednisolone—Nausea—Epirubicin—sarcoma	0.000238	0.000887	CcSEcCtD
Prednisolone—Rash—Doxorubicin—sarcoma	0.000234	0.000871	CcSEcCtD
Prednisolone—Dermatitis—Doxorubicin—sarcoma	0.000234	0.00087	CcSEcCtD
Prednisolone—Headache—Doxorubicin—sarcoma	0.000233	0.000866	CcSEcCtD
Prednisolone—Nausea—Doxorubicin—sarcoma	0.000221	0.000821	CcSEcCtD
Prednisolone—ABCB1—lymph node—sarcoma	0.000187	0.00473	CbGeAlD
